Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
enzyme-treated ecklonia cava extract
- Development stage
- Preclinical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Enzyme-treated Ecklonia cava extract (EEc) is a phlorotannin-rich natural product derived from the brown seaweed *Ecklonia cava* through enzymatic processing with pectinase (Rapidase X-Press L) and cellulase (Rohament CL). This specific extraction method enhances the concentration of bioactive phlorotannins, including eckol, dieckol, and phlorofucofuroeckol-A, with dieckol being the most prominent constituent. EEc has been investigated in preclinical research for its anti-obesity and anti-adipogenic properties. It functions by modulating key transcription factors and signaling pathways involved in lipid metabolism, such as downregulating CCAAT/enhancer-binding protein alpha (C/EBPα), peroxisome proliferator-activated receptor gamma (PPARγ), and sterol regulatory element-binding protein-1c (SREBP-1c). Additionally, it activates AMP-activated protein kinase (AMPK) and increases the expression of adiponectin and glucose transporter type 4 (GLUT4), leading to reduced body weight and improved serum lipid profiles in animal models of high-fat diet-induced obesity.
- Other names
- pectinase and cellulase enzyme-treated Ecklonia cava extract
02
Targets
CEBPA (C/EBPα)AMPK (Adenosine monophosphate–activated protein kinase)CEBPA (CCAAT enhancer-binding protein alpha)PPARG (Peroxisome proliferator-activated receptor gamma)
Beyond the preview
Go deeper on enzyme-treated ecklonia cava extract.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on enzyme-treated ecklonia cava extract.